SCHEMBL25352186

SCHEMBL25352186

CN(C)CCC(=O)Nc1cccc(-c2cn(Cc3ccc(-c4nnc(C(F)F)o4)cc3F)nn2)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 14/20 0.46
▸ HDAC6 Q9UBN7 7/20 0.46
▸ HDAC3 O15379 6/20 0.46
▸ HDAC2 Q92769 4/20 0.46
▸ HDAC10 Q969S8 4/20 0.46
▸ HDAC8 Q9BY41 4/20 0.46
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ FBP1 P09467 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30408994 0.92 HDAC1 (0.44) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL25349206 0.92 HDAC1 (0.44) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL30409726 0.88 UCHL5 (0.49) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL24215838 0.88 UCHL5 (0.49) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL25350937 0.88 HDAC6 (0.44) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL25992763 0.87 HDAC1 (0.42) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL25993048 0.87 KDM4E (0.42) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL25351671 0.87 HDAC6 (0.47) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL25993017 0.86 KDM4E (0.52) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL24216545 0.85 KDM4E (0.44) HDAC1HDAC6HDAC3HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC1 2/4885HDAC6 1/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback